Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer</p>
Shiqiang Wang, Chongling Hu, Fei Xie, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 667-683
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani, James A. Holden, Wenyi Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 113
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
Olivier Michielin, Aly‐Khan A. Lalani, Caroline Robert, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003024-e003024
Open Access | Times Cited: 35
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Jiexi Wen, Jie Zeng Yu, Catherine Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2044-2044
Open Access | Times Cited: 7
Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis
Ruoyue Fan, Jiaqi Wu, Yuyang Liu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 21
Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma
Zhiyong Deng, Liang Cui, Pansong Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 20
Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer
Bin Wang, Hanfei Guo, Haiyang Xu, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2620-2620
Open Access | Times Cited: 20
Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
Likui Fang, Wuchen Zhao, Bo Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Efficacy of PD ‐1/ PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China
Jiamin Sheng, Hui Li, Xiaoqing Yu, et al.
Thoracic Cancer (2021) Vol. 12, Iss. 22, pp. 3019-3031
Open Access | Times Cited: 18
Zimberelimab combined with systemic therapy extended tumor control in post‐radiotherapy cervical cancer with brain metastases: A case report
Bingqiang Ni, Mingmei Pan, Lianxiang He, et al.
Journal of Obstetrics and Gynaecology Research (2024) Vol. 50, Iss. 4, pp. 740-745
Closed Access | Times Cited: 2
Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)
Jean‐Baptiste Assié, R. Corre, Matteo Giaj Levra, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 18
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
Daiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
JTO Clinical and Research Reports (2021) Vol. 2, Iss. 10, pp. 100230-100230
Open Access | Times Cited: 17
Clinical Activity and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Small Cell Lung Cancer
Yanyan Hao, Yi-Peng Qiao, Jian-De Cheng
International Journal of General Medicine (2021) Vol. Volume 14, pp. 10483-10493
Open Access | Times Cited: 16
Comparative Efficacy and Safety of Immunotherapy on Non–Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Network Meta‐Analysis
Tianyi Lyu, Bo Sun, Daowen Yang, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 8
Open Access | Times Cited: 1
Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study.
Ping‐Chih Hsu, Li‐Chung Chiu, Ko‐Ting Chen, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3607-3617
Closed Access | Times Cited: 2
[Research Progress in the Treatment of Brain Metastases 
from Non-small Cell Lung Cancer].
Xue Han, Hongmei Li
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 23, Iss. 12, pp. 1087-1094
Closed Access | Times Cited: 5
Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review
Ming-Hong Xie, Yunlong Zhao, Xiaohua Hou, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
Chengkai Zhang, Wenjianlong Zhou, Dainan Zhang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
An update on the epidemiology, imaging and therapy of brain metastases
Maciej Mielczarek, Anna Kubica, Mateusz Szylberg, et al.
Nowotwory Journal of Oncology (2020) Vol. 70, Iss. 3, pp. 111-117
Open Access | Times Cited: 2
Response of Pembrolizumab Alone for Non-small Cell Lung Cancer With Brain Metastasis: A Case Report and Literature Review
Eric A. Marvin, Kimberley L. Furrow, Ayesha Kar, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 2
Routine Neuroimaging in Patients with Stage IV Non-Small Cell Lung Cancer: A Single Center Experience
Maude Dubé-Pelletier, Catherine Labbé
Current Oncology (2021) Vol. 28, Iss. 2, pp. 1125-1136
Open Access | Times Cited: 2
Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases
Mohini Singh, Ashish Dahal, Priscilla K. Brastianos
Current Protocols (2021) Vol. 1, Iss. 11
Open Access | Times Cited: 2
Miliary Tuberculosis in a Young Patient? Let's Not Forget the Lung Adenocarcinoma!
Zeeshan Zia, Qasim Z Iqbal, Naureen Narula, et al.
Cureus (2020)
Open Access | Times Cited: 1
Brain Metastases: Current and Future Pharmacological Treatment
Erika Horta, Tobias Walbert
Springer eBooks (2022), pp. 559-565
Closed Access | Times Cited: 1
Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases
Yu Huang, Huanhuan Li, Ling Peng, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 9, pp. 9974-9983
Open Access | Times Cited: 1
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion
Chinami Masuda, Mamiko Morinaga, Daiko Wakita, et al.
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 2, pp. 335-344
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top